Andrew Feifer

Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study

2023 · 14 Zit. · The Lancet Digital Health

MP61-02 DEVELOPMENT, MULTI-INSTITUTIONAL EXTERNAL VALIDATION, AND ALGORITHMIC AUDIT OF SEPERA - AN ARTIFICIAL INTELLIGENCE-BASED SIDE-SPECIFIC EXTRA-PROSTATIC EXTENSION RISK ASSESSMENT TOOL FOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY

2023 · 0 Zit. · The Journal of Urology